Log in to search using one of your social media accounts:

 

Birth Control Pill Tied to Slight Rise in Breast Cancer Risk
WEDNESDAY, Dec. 6, 2017 -- Newer versions of the birth control pill carry a similar increased risk of breast cancer as earlier ones that were abandoned in the 1990s, a new study reveals. Women taking modern formulations of the pill have a 20... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2017 Category: General Medicine Source Type: news

Staging Breast Cancer With PET/MRI Staging Breast Cancer With PET/MRI
A new study suggests that PET/MRI adds value in the staging of breast cancer compared with standard-of-care imaging.Medscape Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2017 Category: Consumer Health News Tags: Radiology Viewpoint Source Type: news

New Breast Cancer Drug Ribociclib (Kisqali) May Benefit Younger Women, Too
WEDNESDAY, Dec. 6, 2017 -- Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found. The drug, called ribociclib (Kisqali), was approved by the U.S. Food and Drug... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2017 Category: General Medicine Source Type: news

New Breast Cancer Drug May Benefit Younger Women, Too
WEDNESDAY, Dec. 6, 2017 -- Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found. The drug, called ribociclib (Kisqali), was approved by the U.S. Food and Drug... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2017 Category: General Medicine Source Type: news

Breast Cancer Surgery May Soon Be Completed Successfully without Requiring Clinical Laboratory Testing and Pathology Reports
Proof-of-concept research investigates whether photoacoustic imaging can be used in place of traditional tissue staining procedures during cancer surgery to determine if all of the tumor has been removed Determining where breast cancer ends and healthy tissue begins is a critical part of breast cancer surgery. Surgeons are used to working closely during surgery with […] (Source: Dark Daily)
Source: Dark Daily - December 6, 2017 Category: Laboratory Medicine Authors: Jude Tags: Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Pathology Laboratory Testing Management & Operations anatomic pathology California Institute of Technolog Source Type: news

FDA recognizes radiotherapy readiness standard
The U.S. Food and Drug Administration (FDA) has recognized the RT-2 Radiotherapy...Read more on AuntMinnie.comRelated Reading: ASTRO: Short radiation course safe for breast cancer Radiotherapy boost based on PET not always helpful ASTRO releases oropharyngeal cancer guidelines ASTRO updates guidelines on painful bone metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 6, 2017 Category: Radiology Source Type: news

Rotating Night-Shift Work and the Risk of Breast Cancer Rotating Night-Shift Work and the Risk of Breast Cancer
This study found a strong positive association with breast cancer among women who had accumulated 20 years or more of rotating night-shift work in early adulthood.American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Diabetes drug metformin inhibits multidrug-resistant breast cancer
(PLOS) The drug metformin, typically prescribed to treat type 2 diabetes, keeps breast cancer cells from developing multiple drug resistance (MDR) and can reverse MDR after it ¹ s appeared, according to a study published Dec. 6, 2017 in the open-access journal PLOS ONE by Terra Arnason from the University of Saskatchewan, Canada, and colleagues. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2017 Category: Cancer & Oncology Source Type: news

Contrast-enhanced digital mammography comparable to breast MRI after therapy or chemo
(Mayo Clinic) Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to the results of a study presented by Mayo Clinic researchers today at the 2017 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2017 Category: Cancer & Oncology Source Type: news

Widespread screening for breast cancer didn't do much to save women's lives, study finds
Breast cancer deaths have declined markedly in the Netherlands since a nationwide screening program began in 1989, but mammograms deserve little — if any — of the credit, a new study suggests.In fact, the main impact of inviting Dutch women between the ages of 50 and 74 to get a mammogram every... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - December 6, 2017 Category: Science Authors: Karen Kaplan Source Type: news

Breast cancer screening has ‘little impact’ on cancer deaths
Over-diagnosis of cases is rising, warns study Related items fromOnMedica Experts recommend anastrozole for postmenopausal women with family history of breast cancer The genetics of breast cancer NICE approves breakthrough breast cancer drugs Breast cancer screening Breast cancer screening reduces risk of death (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 6, 2017 Category: UK Health Source Type: news

Consistently lower cancer survival rates for black patients in U.S.
(Reuters Health) - Whether it's colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

San Antonio Breast Cancer Symposium Highlights
Highlights from the 2017 San Antonio Breast Cancer Symposium. (Source: WebMD Health)
Source: WebMD Health - December 5, 2017 Category: Consumer Health News Source Type: news

Personalized breast cancer screening study launches
A five-year study that will investigate whether personalized approaches to...Read more on AuntMinnie.comRelated Reading: USPSTF's breast cancer screening recs dampen compliance Mammo recalls don't keep women from other tests Most women prefer annual breast cancer screening Overweight women need more frequent mammograms New study to tackle personalized breast screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 5, 2017 Category: Radiology Source Type: news

27 Top Breast Cancer Oncologists, Picked By Big Data
A company called Grand Rounds combs through data on physicians to match patients with, it claims, the best doctor for them. Here's who it's algorithm identifies as the top breast cancer doctors in the country. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 5, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Breast Cancer Oncologists Honor Roll
(Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 5, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

No additional risks from pausing hormone-sensitive breast cancer therapy
According to a study, published inThe Lancet, the effectiveness of breast cancer therapy was not adversely affected by patients taking a break from long-term hormone treatments.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 5, 2017 Category: Endocrinology Source Type: news

Racial disparities persist in the survival of patients with ovarian, colon, and breast cancer
(Wiley) Three new articles present trends in survival for patients with ovarian, colon, and breast cancer in the United States by race and stage. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2017 Category: International Medicine & Public Health Source Type: news

Can magnets really ease the side-effects of chemo?
Five years ago, a patient told breast surgeon Tena Walters about a new option to deal with the side-effects of breast cancer treatment — wearing a magnet attached to underwear. (Source: the Mail online | Health)
Source: the Mail online | Health - December 5, 2017 Category: Consumer Health News Source Type: news

The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ
Malignant tumors reprogram cellular metabolism to support cancer cell proliferation and survival. Although most cancers depend on a high rate of aerobic glycolysis, many cancer cells also display addiction to glutamine. Glutamine transporters and glutaminase activity are critical for glutamine metabolism in tumor cells. We found that the receptor tyrosine kinase EphA2 activated the TEAD family transcriptional coactivators YAP and TAZ (YAP/TAZ), likely in a ligand-independent manner, to promote glutamine metabolism in cells and mouse models of HER2-positive breast cancer. Overexpression of EphA2 induced the nuclear accumula...
Source: Signal Transduction Knowledge Environment - December 5, 2017 Category: Science Authors: Edwards, D. N., Ngwa, V. M., Wang, S., Shiuan, E., Brantley-Sieders, D. M., Kim, L. C., Reynolds, A. B., Chen, J. Tags: STKE Research Articles Source Type: news

Breast cancer, environment featured in California community forum
A focus on breast cancer drew upwards of 100 people to an NIEHS community forum sponsored by the City of Hope Medical Center. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - December 4, 2017 Category: Environmental Health Source Type: news

Nigeria:Mrs. Akeredolu Goes Pink for Breast Cancer in Nigeria
[Guardian] In the last 30 years, cancer has become the deadliest non-communicable disease responsible for more deaths than HIV/AIDS, malaria and tuberculosis combined. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 4, 2017 Category: African Health Source Type: news

Flight attendant battling two cancers gets the all clear
Doaa Abouelseoud, from Cairo, Egypt, battled stage three breast cancer and rare Hodgkin Lymphoma. She says the ordeal has given her a completely new positive outlook on life. (Source: the Mail online | Health)
Source: the Mail online | Health - December 4, 2017 Category: Consumer Health News Source Type: news

Social Contagion and Adoption of Imaging in Breast Cancer Social Contagion and Adoption of Imaging in Breast Cancer
Physicians affect other physicians. How do new approaches to cancer care disseminate into clinical practice?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 4, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Physicians' experiences with family and friends impact breast cancer screening
(Johns Hopkins Medicine) Results of a national survey of more than 800 physicians suggest that their experiences with patients, family members and friends with breast cancer are linked with their recommendations for routine mammograms. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2017 Category: Cancer & Oncology Source Type: news

A new role for an old protein in breast cancer
(University of Kent) A new role for an old protein in breast cancerPotential new treatments may result from research carried out by the University of Kent that has found a new interaction between one of the proteins in our bodies and hormones in breast cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2017 Category: Cancer & Oncology Source Type: news

How a New Genomic Test Could Change Cancer Care
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the U.S. Food and Drug Administration (FDA) approved FoundationOne CDx™, the company’s comprehensive companion diagnostic test for solid tumors. FoundationOne CDx is intended for use by health care professionals to help inform cancer treatment management in accordance with professional guidelines for patients with solid tumors. The first and only FDA-approved test of its kind for all solid tumors, FoundationOne CDx is a diagnostic test that acts as: “Access to important genomic information is ...
Source: MDDI - December 1, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Source Type: news

FDA OKs Mylan's biosimilar of Roche cancer drug Herceptin
(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar of Herceptin, Roche's blockbuster treatment for breast cancer, making it the second copycat drug for cancer approved in the United States. (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Biosimilar Trastuzumab for HER+ Breast Cancer FDA Approves Biosimilar Trastuzumab for HER+ Breast Cancer
The agency has approved the first biosimilar that corresponds to Herceptin for use in HER2+ breast and metastatic stomach cancer.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 1, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves'Biosimilar' Drug Ogivri for Breast, Stomach Cancers
Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Medicines, Stomach Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 1, 2017 Category: Consumer Health News Source Type: news

FDA approves Mylan's biosimilar of Roche's cancer drug Herceptin
(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar version of Roche's blockbuster breast cancer treatment Herceptin. (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves first biosimilar for the treatment of certain breast and stomach cancers
Ogivri, a biosimilar to the cancer drug Herceptin, is approved for HER2+ breast cancer and metastatic stomach cancers SILVER SPRING, Md., Dec. 1, 2017 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration today approved Ogiv... Biopharmaceuticals, Oncology, FDA Mylan, Ogivri, trastuzumab-dkst, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 1, 2017 Category: Pharmaceuticals Source Type: news

FDA approves first biosimilar for the treatment of certain breast and stomach cancers
The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or stomach cancer and the second biosimilar approved in the U.S. for the treatment of cancer. (Source: World Pharma News)
Source: World Pharma News - December 1, 2017 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Breast cancer patients don't trust the system and want better treatment, according to new study
(Natural News) A growing number of breast cancer patients are beginning to trust their own instincts and go against their doctor’s advice. In a new survey, nearly one third of women with breast cancer chose to forgo the full, recommended course of chemotherapy, radiation, or hormone therapy, post-surgery. Health authorities find this troubling because “treatment... (Source: NaturalNews.com)
Source: NaturalNews.com - December 1, 2017 Category: Consumer Health News Source Type: news

Fast MRI Improves Breast Cancer Screening
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 1, 2017 Category: General Medicine Source Type: news

Alcohol Intake, Binge Drinking, and Breast Cancer Risk Alcohol Intake, Binge Drinking, and Breast Cancer Risk
Alcohol is a known risk factor for breast cancer. Does binge drinking increase the risk?American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

FDA Approves 'Biosimilar' Drug Ogivri for Breast, Stomach Cancers
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 1, 2017 Category: Cancer & Oncology Source Type: news

Do Cancer-Related Fatigue and Physical Activity Vary by Age for Black Women With a History of Breast Cancer?
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - November 30, 2017 Category: International Medicine & Public Health Source Type: news

Fast MRI Improves Breast Cancer Screening Fast MRI Improves Breast Cancer Screening
The diagnostic speed and accuracy of breast cancer screening could be better with abbreviated MRI than with mammography, and faster protocols could also work for other conditions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 30, 2017 Category: Consumer Health News Tags: Radiology News Source Type: news

Distrust In Health-Care System Might Prevent Breast Cancer Patients From Getting Recommended Care
Breast cancer patients who said they didn't trust the health-care system were less likely to get follow-up chemotherapy or hormonal or radiation therapy as recommended by their physician after their initial treatment. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 30, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Source Type: news

Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
Panel provides for the most comprehensive coverage of single-cell biomarkers for clinical trial research SAN DIEGO, Nov. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Epic Sciences, Inc. announces the release of its breast cancer single-cell pr... Diagnostics, Oncology, Product Launch Epic Sciences, circulating tumor cells, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 30, 2017 Category: Pharmaceuticals Source Type: news

Primary Small Cell Carcinoma of the Breast: A Case Report Primary Small Cell Carcinoma of the Breast: A Case Report
This case report sheds light on small cell carcinoma of the breast, a rarely described subtype of neuroendocrine breast cancer, providing a comprehensive approach to diagnosis and management.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 30, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Shifting protein networks in breast cancer may alter gene function
(PLOS) A given gene may perform a different function in breast cancer cells than in healthy cells due to changes in networks of interacting proteins, according to a new study published in PLOS Computational Biology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2017 Category: Cancer & Oncology Source Type: news

Regional breast cancer guidelines needed in the Middle East and North Africa
(ecancermedicalscience) Researchers surveying breast cancer management in the Middle East and North Africa (MENA) region have identified significant barriers to applying international guidelines, and are calling for localized best practice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2017 Category: Cancer & Oncology Source Type: news

New vaccine technique effectively fights breast cancer in mice
(University of Copenhagen The Faculty of Health and Medical Sciences) The body's own immune system can effectively fight breast cancer with the help of a new vaccine technique, researchers from the University of Copenhagen show in mice trials. The technique holds great potential if the effect translates to humans, the researchers find. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2017 Category: Cancer & Oncology Source Type: news

Women's Wellness: Comparing breast imaging tools
DEAR MAYO CLINIC:?After a recent mammogram, my doctor suggested an additional test. She recommended molecular breast imaging, but, when I got to the appointment, I was scheduled for 3-D imaging. What is the difference between the two? Is one more accurate than the other at detecting breast cancer? ANSWER:?Both?molecular breast imaging?and a 3-D mammogram, also [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 30, 2017 Category: Databases & Libraries Source Type: news

Niko ’s Olympic Coney Island raises awareness, funds during Breast Cancer Awareness Month
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - November 29, 2017 Category: Cancer & Oncology Source Type: news

Urban American-Indian, Alaskan natives may have lower survival following invasive cancer
(American Association for Cancer Research) Compared with the non-Hispanic white population, the urban American-Indian and Alaskan Native community was more likely to have lower survival rates following invasive prostate and breast cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 29, 2017 Category: International Medicine & Public Health Source Type: news

San Antonio Breast Cancer Symposium (SABCS) 2017 San Antonio Breast Cancer Symposium (SABCS) 2017
Read clinically focused news coverage of key developments from SABCS 2017.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 28, 2017 Category: Consumer Health News Tags: Conference Coverage Source Type: news

What's Hot at SABCS 2017? What's Hot at SABCS 2017?
Can the duration of adjuvant therapy in breast cancer be reduced? Is trastuzumab effective in HER2-negative tumors? These are among the hot topics that will be discussed.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news